Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

804 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools.
Hasanzadeh A, Ebadati A, Dastanpour L, Aref AR, Sahandi Zangabad P, Kalbasi A, Dai X, Mehta G, Ghasemi A, Fatahi Y, Joshi S, Hamblin MR, Karimi M. Hasanzadeh A, et al. Among authors: hamblin mr. ACS Pharmacol Transl Sci. 2023 Nov 14;6(12):1758-1779. doi: 10.1021/acsptsci.3c00102. eCollection 2023 Dec 8. ACS Pharmacol Transl Sci. 2023. PMID: 38093832 Review.
Tumor-derived exosomal non-coding RNAs as diagnostic biomarkers in cancer.
Ebrahimi N, Faghihkhorasani F, Fakhr SS, Moghaddam PR, Yazdani E, Kheradmand Z, Rezaei-Tazangi F, Adelian S, Mobarak H, Hamblin MR, Aref AR. Ebrahimi N, et al. Among authors: hamblin mr. Cell Mol Life Sci. 2022 Oct 29;79(11):572. doi: 10.1007/s00018-022-04552-3. Cell Mol Life Sci. 2022. PMID: 36308630 Review.
Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis.
Taheriazam A, Abad GGY, Hajimazdarany S, Imani MH, Ziaolhagh S, Zandieh MA, Bayanzadeh SD, Mirzaei S, Hamblin MR, Entezari M, Aref AR, Zarrabi A, Ertas YN, Ren J, Rajabi R, Paskeh MDA, Hashemi M, Hushmandi K. Taheriazam A, et al. Among authors: hamblin mr. J Control Release. 2023 Feb;354:503-522. doi: 10.1016/j.jconrel.2023.01.028. Epub 2023 Jan 19. J Control Release. 2023. PMID: 36641122 Review.
Receptor tyrosine kinase inhibitors in cancer.
Ebrahimi N, Fardi E, Ghaderi H, Palizdar S, Khorram R, Vafadar R, Ghanaatian M, Rezaei-Tazangi F, Baziyar P, Ahmadi A, Hamblin MR, Aref AR. Ebrahimi N, et al. Among authors: hamblin mr. Cell Mol Life Sci. 2023 Mar 22;80(4):104. doi: 10.1007/s00018-023-04729-4. Cell Mol Life Sci. 2023. PMID: 36947256 Free PMC article. Review.
Recent advances in 3D bioprinted tumor models for personalized medicine.
Gnatowski P, Piłat E, Kucińska-Lipka J, Saeb MR, Hamblin MR, Mozafari M. Gnatowski P, et al. Among authors: hamblin mr. Transl Oncol. 2023 Nov;37:101750. doi: 10.1016/j.tranon.2023.101750. Epub 2023 Aug 10. Transl Oncol. 2023. PMID: 37572498 Free PMC article.
804 results